ACASTI PHARMA INC (ACST)

CA00430K8656 - Common Stock

2.9285  +0.03 (+0.98%)

After market: 3.04 +0.11 (+3.81%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-3-31)
2022
(2022-3-31)
2021
(2021-3-31)
2020
(2020-3-31)
Revenue
0.000.000.00200.00K0.00
Cost Of Goods
N/AN/A0.0080.00KN/A
Gross Profit
N/AN/A0.00120.00KN/A
Operating Expenses
12.22M18.25M15.34M10.84M24.44M
Research and Development
2.17M2.33M2.46M1.81M2.20M
Selling, General, and Administrative Expenses
7.62M8.21M9.78M6.66M8.46M
Operating Income
-12.22M-18.25M-15.34M-10.72M-24.44M
Interest Income/Expense
-856.00K180.00K4.98M-3.00M-1.03M
Other Income/Expense
N/A0.00150.00K-260.00K-50.00K
Non Recurring Items
-35.43M-33.91M-250.00K-5.70M0.00
Income Before Taxes
-48.59M-51.97M-10.47M-19.68M-25.51M
Income Tax
-9.82M-9.54M-650.00KN/AN/A
Net Income
-38.77M-42.43M-9.82M-19.68M-25.51M
EBITDA
N/A-18.13MN/A-9.80M-22.12M
 
Per Share Data
EPS Diluted Total Ops
-5.06-5.71-1.60-7.96-14.48
Non GAAP EPS
N/AN/AN/AN/AN/A
 
Statistics
Gross Profit Margin
N/AN/AN/A60.00%N/A
Profit Margin
N/AN/AN/A-9840.00%N/A
Operating Profit Margin
N/AN/AN/A-5360.00%N/A

All data in USD

Charts